Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Lannett (M, US) Pharmaceuticals
1. Lannett (M, US) Pharmaceuticals
82
29
89
71
2. Prestige (L, US) Pharmaceuticals
2. Prestige (L, US) Pharmaceuticals
62
57
30
57
3. Pfizer (XXL, US) Pharmaceuticals
3. Pfizer (XXL, US) Pharmaceuticals
60
47
17
34
4. AbbVie (XXL, US) Biotechnology
4. AbbVie (XXL, US) Biotechnology
49
88
9
44
5. Phibro Animal (L, US) Pharmaceuticals
5. Phibro Animal (L, US) Pharmaceuticals
46
62
64
75
November 16, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Nektar (L, US) Pharmaceuticals
1. Nektar (L, US) Pharmaceuticals
21
100
86
89
2. Supernus Pharma (M, US) Pharmaceuticals
2. Supernus Pharma (M, US) Pharmaceuticals
11
88
54
100
3. AbbVie (XXL, US) Biotechnology
3. AbbVie (XXL, US) Biotechnology
49
88
9
44
4. Catalent (L, US) Pharmaceuticals
4. Catalent (L, US) Pharmaceuticals
30
78
38
89
5. Zoetis (XL, US) Pharmaceuticals
5. Zoetis (XL, US) Pharmaceuticals
20
75
50
88
6. Eli Lilly (XXL, US) Pharmaceuticals
6. Eli Lilly (XXL, US) Pharmaceuticals
6
69
23
19
7. Phibro Animal (L, US) Pharmaceuticals
7. Phibro Animal (L, US) Pharmaceuticals
46
62
64
75
8. Prestige (L, US) Pharmaceuticals
8. Prestige (L, US) Pharmaceuticals
62
57
30
57
9. Pacira BioSciences (M, US) Pharmaceuticals
9. Pacira BioSciences (M, US) Pharmaceuticals
2
56
31
33
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
13
50
29
16
November 16, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Lannett (M, US) Pharmaceuticals
1. Lannett (M, US) Pharmaceuticals
82
29
89
71
2. Nektar (L, US) Pharmaceuticals
2. Nektar (L, US) Pharmaceuticals
21
100
86
89
3. Phibro Animal (L, US) Pharmaceuticals
3. Phibro Animal (L, US) Pharmaceuticals
46
62
64
75
4. Supernus Pharma (M, US) Pharmaceuticals
4. Supernus Pharma (M, US) Pharmaceuticals
11
88
54
100
5. Zoetis (XL, US) Pharmaceuticals
5. Zoetis (XL, US) Pharmaceuticals
20
75
50
88
6. Akorn (M, US) Pharmaceuticals
6. Akorn (M, US) Pharmaceuticals
33
1
50
29
November 16, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
11
88
54
100
2. Nektar (L, US) Pharmaceuticals
2. Nektar (L, US) Pharmaceuticals
21
100
86
89
3. Catalent (L, US) Pharmaceuticals
3. Catalent (L, US) Pharmaceuticals
30
78
38
89
4. Zoetis (XL, US) Pharmaceuticals
4. Zoetis (XL, US) Pharmaceuticals
20
75
50
88
5. Phibro Animal (L, US) Pharmaceuticals
5. Phibro Animal (L, US) Pharmaceuticals
46
62
64
75
6. Lannett (M, US) Pharmaceuticals
6. Lannett (M, US) Pharmaceuticals
82
29
89
71
7. Prestige (L, US) Pharmaceuticals
7. Prestige (L, US) Pharmaceuticals
62
57
30
57
November 16, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value , Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from November 16, 2018.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Jan‑2014